
|Articles|November 1, 2003
Sight preserved in AMD patients receiving steroid derivative
New York-More drugs are in the pipeline that may have a positive impact on the treatment of patients with age-related macular degeneration (AMD). One that is providing good results is anecortave acetate (15 mg) for depot suspension, (Retaane, Alcon).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Opuviz aflibercept biosimilar launches in Europe for retinal diseases
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















